LDL-cholesterol: the lower the better! We need a new lipid lowering drugs? Focus on alirokumab (Praluent)

Abstract

This article provides a brief overview of the development of atherosclerosis and preventative cardiology, development of morbidity and mortality.

Keywords

• Cardiovascular disease
• lipid lowering drugs
• statins
• ezetimibe
• LDL-cholesterol
• Praluent